NHS National Pharmaceuticals Transition 2022_1
Details
- Supplier(s)
42 suppliers
- Accord UK Ltd
- Alturix
- Amarox Ltd
- Aspen Pharmacare UK Limited
- B. BRAUN MEDICAL LIMITED
- Celix Pharma Ltd.
- Chiesi Ltd
- clinigen healthcare limited
- Consilient Health Ltd
- Day Lewis Medical Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Ennogen HealthCare
- Esteve Pharmaceuticals Ltd
- Flexipharm Austrading Ltd
- FLYNN PHARMA LTD
- FRESENIUS KABI LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Kent Pharma Ltd
- Macure Pharma ApS
- medac Pharma LLP
- Mercury Pharmaceuticals Ltd
- Milpharm Ltd/aurobinbdo
- Morningside Pharmaceuticals Ltd
- Mylan
- Napp Pharmaceuticals Ltd
- Neon Healthcare Ltd
- Norgine Pharmaceuticals Limited
- Panpharma UK Ltd
- Pfizer Liimted
- Piramal Critical Care Ltd
- Ranbaxy UK
- RELONCHEM LIMITED
- Roche Products Ltd
- Roma Pharmaceuticals Limited
- Rosemont Pharmaceuticals Ltd
- Sandoz
- Selective Supplies Ltd
- Sintetica Ltd
- Teva UK Ltd
- Tillomed Laboratories Ltd
- Wockhardt UK Limited
- Zentiva Pharma UK Ltd
- Value
- £39,636,345
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 12 August 2022
- Source
- uk:contracts_finder
Tender description
Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months) Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months) Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months)
Timeline
- Completed: Award date19 July 2022
- Completed: Award published12 August 2022Current notice
- Completed: Contract expiry date31 May 2024
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
13 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Generic Drugs - Oral Liquids
- Open tender
Injection Equipment Paraphernalia
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 510£244.6m
- 448£1.6bn
- 407£112.7m
- 404£2.0bn
- 326£1.2bn
- 322£24.6bn
- 291£1.6bn
- 248£3.1bn
- 156£125.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.